The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study

被引:57
|
作者
Chemerinski, E [1 ]
Robinson, RG [1 ]
Arndt, S [1 ]
Kosier, JT [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA
关键词
D O I
10.1097/00005053-200107000-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Poststroke depression has been associated with impaired recovery of activities of daily living (ADL) during the first 2 years after stroke. This study examined the effect of remission of poststroke depression on recovery in ADL in a double-blind randomized treatment study. Based on a semistructured psychiatric exam and DSM-IV diagnostic criteria, a consecutive series of 23 patients who met criteria for major depression (N = 16) or minor depression (N = 7) were selected and randomly assigned to either active treatment (nortriptyline) or placebo. Functional physical (i.e., ADL) impairment was assessed using the Johns Hopkins Functioning Inventory (JHFI). Patients whose depressive disorder remitted at follow-up had significantly greater recovery in ADL functions compared with patients whose depression did not ren-dt. There were no differences in demographic variables, lesion characteristics, and neurological symptoms between the two groups, which would explain the significantly greater improvement among the remitted patients. Because both major and minor depression patients who remitted showed greater improvement in ADL than nonremitted patients some of whom were treated with active and some with placebo medication, nonpharmacotherapeutic mechanisms related to recovery from depression appear to mediate this enhanced recovery.
引用
收藏
页码:421 / 425
页数:5
相关论文
共 50 条
  • [1] Double-blind randomized treatment of poststroke depression using nefiracetam
    Robinson, Robert G.
    Jorge, Ricardo E.
    Clarence-Smith, Kathleen
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 20 (02) : 178 - 184
  • [2] Improved recovery in activities of daily living associated with remission of poststroke depression
    Chemerinski, E
    Robinson, RG
    Kosier, JT
    STROKE, 2001, 32 (01) : 113 - 117
  • [3] Treatment of cognitive impairment after poststroke depression - A double-blind treatment trial
    Kimura, M
    Robinson, RG
    Kosier, JT
    STROKE, 2000, 31 (07) : 1482 - 1486
  • [4] Double-Blind Treatment of Apathy in Patients with Poststroke Depression Using Nefiracetam
    Robinson, Robert G.
    Jorge, Ricardo E.
    Clarence-Smith, Kathleen
    Starkstein, Sergio
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 21 (02) : 144 - 151
  • [5] Fluoxetine in early poststroke depression - A double-blind placebo-controlled study
    Wiart, L
    Petit, H
    Joseph, PA
    Mazaux, JM
    Barat, M
    STROKE, 2000, 31 (08) : 1829 - 1832
  • [6] Risperidone treatment of resistant depression: A double-blind randomized trial
    Gharabawi, Georges
    Canuso, Carla
    Pandina, Gahan
    Bossie, Cynthia
    Kujawa, Mary
    Kosik-Gonzalez, Colette
    Turkoz, Ibrahim
    Mahmoud, Ramy
    Shelton, Richard
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S228 - S228
  • [7] Moclobemide versus fluoxetine for double depression: A randomized double-blind study
    Duarte, A
    Mikkelsen, H
    DeliniStula, A
    JOURNAL OF PSYCHIATRIC RESEARCH, 1996, 30 (06) : 453 - 458
  • [8] Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness a double-blind, placebo-controlled study
    Smi, CK
    Han, SW
    Kwon, SU
    Kang, DW
    Choi, JM
    Kim, JS
    STROKE, 2006, 37 (01) : 156 - 161
  • [9] A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia
    de Vasconcelos Cunha, Ulisses Gabriel
    Rocha, Fabio Lopes
    de Melo, Rodrigo Avila
    Valle, Estevao Alves
    de Souza Neto, Jose Julio
    Brega, Rodrigo Mendes
    Scoralick, Francisca Magalhaes
    Silva, Silvana Araujo
    de Oliveira, Flaviana Martins
    da Costa Junior, Antonio Luciano
    Faria Alves, Viviane Xavier
    Sakurai, Emilia
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (01) : 36 - 41